Allovir, Inc. (ALVR) Net Income (Loss) Attributable to Parent USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Allovir, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2024.
  • Allovir, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$30.3 M, a 26.4% increase year-over-year.
  • Allovir, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$180 M, a 8.13% decline year-over-year.
  • Allovir, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$190 M, a 12.9% decline from 2022.
  • Allovir, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$169 M, a 1.89% increase from 2021.
  • Allovir, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$172 M, a 146% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$180 M -$30.3 M +$10.9 M +26.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$190 M -$59.7 M -$21.6 M -56.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$169 M -$44.3 M -$2.2 M -5.23% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 -$167 M -$45.3 M -$628 K -1.41% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-02
Q1 2023 -$166 M -$41.2 M +$2.68 M +6.11% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$169 M -$38.1 M +$19.8 M +34.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$189 M -$42.1 M +$3.44 M +7.55% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$192 M -$44.6 M -$7.05 M -18.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$185 M -$43.9 M -$12.9 M -41.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$172 M -$57.9 M -$32.7 M -130% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-15
Q3 2021 -$139 M -$45.5 M -$21.9 M -92.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$117 M -$37.6 M -$26 M -223% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$91.4 M -$30.9 M -$21.6 M -231% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$69.8 M -$25.2 M -$16.5 M -188% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-10
Q3 2020 -$53.3 M -$23.6 M -$16.3 M -225% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$37 M -$11.6 M -$6.33 M -119% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-05
Q1 2020 -$30.7 M -$9.34 M -$6.82 M -270% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-05
Q4 2019 -$23.8 M -$8.74 M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-12
Q3 2019 -$7.27 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$5.3 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$2.52 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.